FundedChaosBio Deal I
SutureTech
SutureTech develops RapidFix, an FDA-cleared orthopedic suture fixation device designed to simplify soft-tissue repair, with an initial focus on rotator cuff.
- ChaosBio deal
- ChaosBio Deal I
- Year
- 2026
- Sector
- Medical Device
- Subsector
- Surgical Technology
- Stage at investment
- Seed+
- Structure
- ChaosBio SPV
- Company website
- www.suturetech.com ↗
SutureTech is an orthopedic medical device company. Its product, RapidFix, is an FDA-cleared suture fixation device designed to simplify soft-tissue fixation in orthopedic repair procedures.
The company's core market is rotator cuff repair, with early surgical use also occurring in knee and lateral extra-articular tenodesis (LET) procedures. A smaller configuration, RapidFix Mini, has been discussed for foot and ankle and other smaller implant applications.
ChaosBio organized its first SPV, ChaosBio Deal I, to invest in SutureTech in 2026.